Latest News & Updates
Breaking News
2 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Novartis Presents Phase III Kidney Data at ERA 2026 for Vanrafia and Fabhalta
Novartis presents 15 kidney disease abstracts at ERA 2026, including late-breaking Phase III data for Vanrafia and Fabhalta with European regulatory implications.
Pharma Now Editorial Team
Amgen Appoints Madhur Sarin as Director of AI and Data Science Centre of Excellence
Amgen formalises AI leadership with a dedicated COE director, signalling structural integration of data science into manufacturing, quality, and regulatory operations.
Pharma Now Editorial Team
Alembic Pharmaceuticals Appoints Dr. Ramesh Juneja as Head of India Business
Alembic Pharmaceuticals names Dr. Ramesh Juneja as Head of India Business, bringing 30+ years of experience to lead domestic generics operations.
Pharma Now Editorial Team
Enveric Biosciences Achieves Key Safety Milestone for EB-003 Neuroplastogen in Phase I Program
Enveric Biosciences clears a Phase I safety milestone for EB-003, a dual 5-HT2A/5-HT1B neuroplastogen, advancing its clinical development path.
Pharma Now Editorial Team
